Tournament: nano | Round: 2 | Opponent: summit jc | Judge: patrick fox
Pharma innovation is high now and strong IP protection are the only incentive for drug innovation – the plan decks that
Stevens and Ezell 20 Philip Stevens and Stephen Ezell 2-3-2020 "Delinkage Debunked: Why Replacing Patents With Prizes for Drug Development Won’t Work" https://itif.org/publications/2020/02/03/delinkage-debunked-why-replacing-patents-prizes-drug-development-wont-work
The Current System Has Produced a Tremendous Amount of Life-Sciences Innovation The frontier
AND
there—has produced nowhere near a similar level of novel biomedical innovation.
====Innovation is necessary to solve future pandemics, antimicrobial diseases, and bioterror.====
Marjanovic and Fejiao 20 Marjanovic, Sonja, and Carolina Feijao. SonjaMarjanovic, Ph.D., Judge Business School, University of Cambridge. Carolina Feijao, Ph.D. in biochemistry, University of Cambridge; M.Sc. in quantitive biology, Imperial College London; B.Sc. in biology, University of Lisbon. "Pharmaceutical Innovation for Infectious Disease Management: From Troubleshooting to Sustainable Models of Engagement." (2020).
As key actors in the healthcare innovation landscape, pharmaceutical and life sciences companies have
AND
issues are recognised as global threats that could become crises in the future.
Walsh 20, Bryan Walsh, 5-14-2020, "The coronavirus pandemic reawakens bioweapon fears," Axios, https://www.axios.com/coronavirus-pandemic-pathogen-bioweapon-45417c86-52aa-41b1-8a99-44a6e597d3a8.html
The immense human and economic toll of the COVID-19 pandemic only underscores the
AND
could potentially make a dangerous engineered virus, whether deliberately or by accident.